Neuroinflammation and neurodegeneration in Huntington’s disease: genetic hallmarks, role of metals and organophosphates
Authors:
- 17 January 2025
- journal article
- review article
- Published by Springer Nature in neurogenetics
- Vol. 26 (1) , 1-15
Abstract
Huntington’s disease (HDs) is a fatal, autosomal dominant, and hereditary neurodegenerative disorder characterized by progressive motor dysfunction, cognitive decline, and psychiatric disturbances. HD is well linked to mutation in the HTT gene, which leads to an abnormal expansion of trinucleotide CAG repeats, resulting in the production of the mHTT protein and responsible for abnormally long poly-Q tract. These abnormal proteins disrupt cellular processes, including neuroinflammation, endoplasmic reticulum (ER) stress, and mitochondrial dysfunction, ultimately leading to selective neuronal loss in the brain. Epidemiological studies reveal significant regional variability in HDs prevalence, with the highest rates observed in North America and the lowest in Africa. In addition to genetic factors, environmental influences such as exposure to metals, and chemicals, and lifestyle factors like alcohol and tobacco use may exacerbate disease progression. This review explores the molecular mechanisms underlying HDs and emphasize the role of neuroinflammatory mediators and environmental factors, in HD research. Understanding these complex interactions is crucial for developing targeted interventions that can slow or halt the progression of this devastating disease.Keywords
This publication has 113 references indexed in Scilit:
- Cadmium and Its Neurotoxic Effects2024
- Neuromodulation in Parkinson’s disease targeting opioid and cannabinoid receptors, understanding the role of NLRP3 pathway: a novel therapeutic approachInflammopharmacology, 2023
- Prevalence and Incidence of Huntington's Disease: An Updated Systematic Review and Meta‐AnalysisMovement Disorders, 2022
- Pesticides Exposures and Parkinsonism: Experimental and Epidemiological Evidence of Association2022
- Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s diseaseInflammopharmacology, 2021
- Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington’s disease through inhibition of NF-κB mediated neuroinflammatory markers and activation of cAMP/CREB/BDNF signaling pathwayInflammopharmacology, 2021
- Dysfunctional striatal dopamine signaling in Huntington's diseaseJournal of Neuroscience Research, 2019
- Roles of inflammation, neurogenic inflammation, and neuroinflammation in painJournal of Anesthesia, 2018
- Multiple clinical features of Huntington’s disease correlate with mutant HTT gene CAG repeat lengths and neurodegenerationJournal of Neurology, 2018
- The role of glutamate and its receptors in multiple sclerosisJournal of Neural Transmission, 2014